Hi @dachopper,
re your comment " Because... Adult Gvhd is 5 times the number of patients than pediatric", I think you'll find it's even better than that.
The exact quote from CEO Itescu (Feb 28, 2024 Earnings Call) was:
" For adult steroid-refractory acute GVHD, we are collaborating ... to conduct a pivotal trial in adults with this condition in patients who have failed second-line therapies and have no approved therapeutics. This potential market is 5x larger than for pediatric. " (underlining added for emphasis)
and again:
" For adults, adolescents and adults over the age of 12, ruxolitinib is the only approved therapy. And 45% of those who receive ruxolitinib are nonresponders. For the nonresponders, there are no approved therapies."
In other words, it is the adult Ruxolitinib 'non-responder' market ALONE which is 5 x larger than the market for the paediatric indication i.e. those sometimes characterised as RR-aGVHD.
A significant & yet unestimated part of the adult market for SR - aGVHD treatments may 'respond' to Ruxolitinib, and yet attending physicicans may have reservations or outright concerns/ fears about prescribing Ruxolitinib as treatment given it's undeniable toxicity, adverse event profile & Novartis/ Incyte's squirrely behaviour when it comes to producing long-term overall survival i.e. mortality/ morbidity data.
I think we'll find the paradigm shift will generate its own momentum & there will be little need to promote RYONCIL for off-label use.
Cheers
GLTA(LT)H
- Forums
- ASX - By Stock
- MSB
- 2024 Here we go again.
2024 Here we go again., page-496
- There are more pages in this discussion • 113 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.08 |
Change
-0.010(0.92%) |
Mkt cap ! $1.233B |
Open | High | Low | Value | Volume |
$1.10 | $1.11 | $1.05 | $5.002M | 4.632M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5697 | $1.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.09 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5697 | 1.080 |
4 | 52546 | 1.070 |
2 | 13300 | 1.060 |
4 | 39265 | 1.055 |
7 | 46184 | 1.050 |
Price($) | Vol. | No. |
---|---|---|
1.085 | 1000 | 1 |
1.090 | 64118 | 2 |
1.095 | 25760 | 3 |
1.100 | 16660 | 3 |
1.105 | 50000 | 2 |
Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
Last
$1.09 |
  |
Change
-0.010 ( 0.10 %) |
|||
Open | High | Low | Volume | ||
$1.09 | $1.11 | $1.06 | 1181223 | ||
Last updated 15.59pm 14/06/2024 ? |
Featured News
MSB (ASX) Chart |